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Abstract
Background: Organic anion transporters 1 (Oat1) and 3 (Oat3) mediate the transport of organic anions, including frequently
prescribed drugs, across cell membranes in kidney proximal tubule cells. In rats, these transporters are known to be male-
dominant and testosterone-dependently expressed. The molecular mechanisms that are involved in the sex-dependent
expression are unknown. Our aim was to identify genes that show a sex-dependent expression and could be involved in
male-dominant regulation of Oat1 and Oat3.
Methodology/Principal Findings: Promoter activities of Oat1 and Oat3 were analyzed using luciferase assays. Expression
profiling was done using a SurePrint G3 rat GE 8660K microarray. RNA was isolated from renal cortical slices of four adult
rats per sex. To filter the achieved microarray data for genes expressed in proximal tubule cells, transcription database
alignment was carried out. We demonstrate that predicted androgen response elements in the promoters of Oat1 and Oat3
are not functional when the promoters were expressed in OK cells. Using microarray analyses we analyzed 17,406 different
genes. Out of these genes, 56 exhibit a sex-dependent expression in rat proximal tubule cells. As genes potentially involved
in the regulation of Oat1 and Oat3 expression, we identified, amongst others, the male-dominant hydroxysteroid (17-beta)
dehydrogenase 1 (Hsd17b1), B-cell CLL/lymphoma 6 (BCL6), and polymerase (RNA) III (DNA directed) polypeptide G (Polr3g).
Moreover, our results revealed that the transcription factor BCL6 activates promoter constructs of Oat1 and Oat3.
Conclusion: The results indicate that the male-dominant expression of both transporters, Oat1 and Oat3, is possibly not
directly regulated by the classical androgen receptor mediated transcriptional pathway but appears to be regulated by the
transcription factor BCL6.
Citation: Wegner W, Burckhardt BC, Burckhardt G, Henjakovic M (2012) Male-Dominant Activation of Rat Renal Organic Anion Transporter 1 (Oat1) and 3 (Oat3)
Expression by Transcription Factor BCL6. PLoS ONE 7(4): e35556. doi:10.1371/journal.pone.0035556
Editor: Eric Feraille, University of Geneva, Switzerland
Received December 20, 2011; Accepted March 21, 2012; Published April 18, 2012
Copyright:  2012 Wegner et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by Deutsche Forschungsgemeinschaft (DFG; German Research Foundation). The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: maja.henjakovic@med.uni-goettingen.de
Introduction
There are several known differences in the mode of drug action
between men and women, however the effect of sex-dependent
dosages is just beginning to be explored [1]. The reasons for
different drug actions are not entirely clear. Sex differences are
found in the absorption, distribution, metabolism and elimination
of drugs [1–3]. The liver and kidneys are responsible for drug
elimination. Hepatocytes in the liver and proximal tubule cells in
the kidneys express several transport proteins such as members of
the ATP-binding cassette (ABC) transporters, e.g. multidrug
resistance proteins (MRPs), or members of the solute carrier
(SLC) family 22A, e.g. organic anion transporters (OATs) and
organic cation transporters (OCTs), that are involved in the
excretion of endogenous and exogenous substrates [4–6]. Sex
differences in the transport of substrates have been shown and
could contribute to interindividual variations in drug efficacy [7].
In 2010, ‘‘The International Transporter Consortium’’ published
a recommendation as to which of the transport proteins clinically
important in drug absorption and elimination have to be analyzed
in drug development [8]. Amongst others, the human organic
anion transporter 1 (OAT1) and 3 (OAT3) were mentioned as
clinically relevant transporters in the kidneys [8]. Immunohisto-
chemical experiments revealed that OAT1 and OAT3 are
expressed at the basolateral membrane of proximal tubule kidney
cells in humans [9,10] and rats [11,12]. OAT1 and OAT3 are
responsible for the uptake of their substrates from the blood into
the cells and interact with several drugs, e.g. analgesics, antibiotics,
and antivirals [5,13–15]. For example, the often consumed
analgesic ibuprofen is transported by human OAT1 as well as
by OAT3 [16] and causes more adverse drug reactions (ADRs) in
women than in men [17]. For a multitude of different drugs, e.g.
analgesics, ACE-inhibitors, and antihistamines, women have a 1.6-
fold higher risk of getting an ADR compared to men [18]. This
phenomenon could be partially due to sex-dependent differences
in the expression of transporters like OAT1 and OAT3. A lower
expression of OAT1 or OAT3 may decrease drug excretion. Rats
that are often used in preclinical trials exhibit sex-dependent
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compared to females [19]. In rats, expression of Oat1 and Oat3 is
increased by testosterone and decreased by estradiol [19]. The
molecular mechanisms of sex-dependent expression of Oat1 and
Oat3 are still unclear.
The purpose of this study was to identify genes that demonstrate
a sex-dependent expression in rat proximal tubule cells and could
be related to male-dominant expression of Oat1 and Oat3. We
identified as a promising candidate gene BCL6 that shows a male-
dominant expression, and might be involved in the regulation of
Oat1 and Oat3.
Materials and Methods
Cloning of the 59-regulatory regions (promoter) of Oat1-
and Oat3-genes into pGL3-Enhancer
The transcriptional start site of Oat1 and Oat3 was identified by
the alignment of genomic and mRNA sequences from each gene
(GenBank accession numbers: Oat1 genomic, NW_047563.2;
mRNA, NM_017224.2; Oat3 genomic, NW_047563.2; mRNA,
NM_031332.1). Based on rat genomic sequence, promoter
fragments of varying lengths were amplified by polymerase chain
reaction (PCR) using rat genomic DNA (BioCat, Germany) as
templates. Primers shown in Table 1 were designed according to
sequences in the 59-regulatory region. Primer numbering indicated
their position relative to the transcriptional start site (designated as
+1). Amplified PCR products were digested with their corre-
sponding restriction enzymes (New England BioLabs GmbH,
Germany) and ligated into the pGL3-Enhancer vector (Promega,
Germany) (Table 1). The full length promoter construct of Oat1 is
referred to as 22252/+113, the next shorter one as 21666/+113,
and the shortest one as 21226/+113. The promoter constructs for
Oat3 are designated as 22567/+12 for the full length one, 2752/
+12 for the next shorter one, and 2444/+12 for the shortest
promoter construct.
In silico analyses of putative transcription factor binding
sites
For determination of predicted transcription factor binding
sites, based on genomic sequence, 3 kilobase (kb) upstream of the
transcription start site of Oat1 (NW_047563.2) and Oat3
(NW_047563.2) were investigated. The analyses were performed
using MatInspector (http://www.genomatix.de/).
Cell culture, transfection, and luciferase assay
Opossum kidney (OK) cells were purchased from LGC
Standards (Germany; European distributor for ‘‘ATCC cultures
and bioproducts’’; ATCCH number: CRL-1840
TM). OK cells
were cultured in Quantum 286 medium (complete medium for
epithelial cells with L-glutamine, PAA Laboratories GmbH,
Austria) with 100 units/ml penicillin and 100 mg/ml streptomycin
(PAA Laboratories GmbH, Austria) at 37uC in a 5% CO2-95% air
humidified incubator. Cells (0.75610
5 cells/well) were seeded into
24-well culture plates in their appropriate culture medium without
antibiotics, incubated up to 24 h and then transiently transfected
using Lipofectamine
TM 2000 (Invitrogen, Germany) according to
the manufacturer’s recommendations. OK cells were transfected
at a confluence of approximately 70% with 0.5 mg promoter
construct (Oat1, Oat3) or pGL3-Enhancer (Promega, Germany),
0.5 mg rPb-Luc, the minimal promoter of rat probasin cloned in
pGL3-Basic (kind gift from Silke Kaulfuss, Institute of Human
Genetics, University of Go ¨ttingen, and described in [20]) or
Table 1. Cloning of different promoter constructs of Oat1 and Oat3.
Position Sequence Enzyme Backbone vector
Oat1 (21226/+113)
21226 to 21207 59-ggGCTAGCAGTGAGATGACAGGCAAAGG-39 NheI/XhoI pGL3-Enhancer
+94 to +113 59-ggCTCGAGATGGTGACCTGGATCAACTG-39
Oat1 (21666/+113)
21666 to 21647 59-ggGCTAGCCAGAGTGAGTTCCAGGACAG-39 NheI/NdeI Oat1 (21226/+113)
21131 to 21111 59-ggggggGCATGGAGGTCTGAGGATAAC-39
Oat1 (22252/+113)
22252 to 22232 59-ggGCTAGCCTGCCCAAGATGATTTTGAAC-39 NheI/BbvCI Oat1 (21666/+113)
21545 to 21526 59-gcgcgATTGGAGCTGAGGACTGAAC-39
Oat3 (2444/+12)
2444 to 2425 59-ggGAGCTCCCCTAACATTCTCCACGAAC-39 SacI/XhoI pGL3-Enhancer
27t o+12 59-ggCTCGAGAGGACAGCTCAGCTCTAAC-39
Oat3 (2752/+12)
2752 to 2732 59-ggGAGCTCGGAGAACAGACAACCACATAC-39 SacI/XhoI pGL3-Enhancer
27t o+12 59-ggCTCGAGAGGACAGCTCAGCTCTAAC-39
Oat3 (22567/+12)
21823 to 21802 59-gggGAGCTCGGCCAACTAGGAACTAGAAAAG-39 SacI/AvrII Oat3 (2752/+12)
2685 to 2665 59-gcggcgggCAAGCCAACACAAACTGAATC-39
22631 to 22613 59-TGAGATGAGGACAACGGAC-39 SacI/PstI Oat3 (21823/+12)
21702 to 21681 59-TTAAATTATACTCCAAGGCCGC-39
Oat: organic anion transporter; bold nucleotides: artificial restriction sites (not included in numbering); small italic nucleotides: adjustment of primer melting
temperature (not included in numbering).
doi:10.1371/journal.pone.0035556.t001
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lymphoma 6 (BCL6) expression vector pcDNA3-BCL6 (kind gift
from Giovanna Roncador, Monoclonal Antibodies Unit Centro
Nacional de Investigaciones Oncolo ´gicas, Spain, and described in
[21]) or 0.5 mg empty vector pcDNA3, 0.1 mg of the rat androgen
receptor (rAR) expression vector pSG5-rAR (kind gift from Olli A.
Ja ¨nne, Institute of Biomedicine, University of Helsinki, Finland,
and described in [22]) or 0.1 mg empty vector pSG5 and 25 ng
pRL-TK (Renilla reniformis vector, Promega, Germany) as indicated
in the figures. Five hours after transfection of OK cells, medium
was changed to complete medium with antibiotics in case of
BCL6-transfection. For rAR-transfection medium was supple-
mented with 100 nM testosterone (Fluka, Germany) dissolved in
dimethyl sulfoxide (DMSO) (AppliChem, Germany), or control
0.0003% DMSO, in the absence of antibiotics. Incubations were
stopped after 43 h and firefly and Renilla luciferase activity were
determined using the Dual-LuciferaseH Reporter Assay System
(Promega, Germany). The luminescences were measured using
Mithras LB940 luminometer (Berthold, Germany). Firefly lucifer-
ase activity was normalized to Renilla luciferase activity. Data are
presented as the fold increase over pGL3-Basic or pGL3-Enhancer
activity.
Immunofluorescence analysis of BCL6- and rAR-
expression
OK cells were seeded (0.75610
5 cells/well) on poly-D-lysine
(Sigma Aldrich, Germany) coated cover slips into 24-well culture
plates. Cells were transiently transfected with either 0.1 mg pSG5-
rAR or control pSG5 for rAR-expression or with 0.5 mg pcDNA3-
BCL6 or control pcDNA3 for BCL6-expression as described
above. 43 h after transfection cells were fixed in 3.7% parafor-
maldehyde (Merck, Germany) in phosphate buffered saline (PBS)
(Applichem, Germany) for 8 min at room temperature (RT), and
subsequently permeabilized for 5 min at RT in a buffer consisting
of 50 mM Na2HPO4/NaH2PO4, pH 7.4; 0.5 mM NaCl, 0.3%
Triton X-100 (Carl Roth, Germany). For staining, antibodies were
diluted in PBS containing 0.1% bovine serum albumin (BSA) (Carl
Roth, Germany). Cells were first incubated for 2 h at RT with
0.5 mg/ml rabbit anti-rat AR polyclonal antibody (Santa Cruz,
USA) or 0.5 mg/ml mouse anti-human BCL6 monoclonal
antibody (Santa Cruz, USA), blocked with 1% BSA for 15 min
at RT, incubated for 1 h at RT with 8 mg/ml Alexa FluorH 488
labeled goat anti-rabbit IgG (H+L) (Invitrogen, Germany) or
8 mg/ml Alexa FluorH 488 labeled goat anti-mouse IgG (H+L)
(Invitrogen, Germany), and finally incubated for 5 min at RT with
300 nM 49,6-diamidino-2-phenylindole dihydrochloride (DAPI)
(Invitrogen, Germany). Cells were washed with PBS and
investigated by fluorescence microscopy. For evaluation of
transfection efficiency, cells were investigated under a 206
magnification and five pictures across one cover slip were made.
Using Image J (version 1.44, National Institutes of Health, USA),
DAPI (blue) stained cells were counted and set as 100%. BCL6-
and rAR-positive cells, stained in green, were further counted and
their ratio to DAPI stained cells was calculated. The mean of all
five pictures was estimated and is referred as transfection efficiency
in %.
Ethic statement
N/A
Animals
RCCHan
TM:WIST rats were obtained from Harlan Laborato-
ries (Venray, Netherlands). Animals were kept in the animal
facility of the University Medical Center Go ¨ttingen under
conventional housing conditions (22uC, 55% humidity, and 12 h
day/night cycle) given free access to water and rat chow.
Acclimatization period was at least 14 days. Four male and four
female rats were anesthetized with CO2 and euthanized by
cervical dislocation. The kidneys were extracted post mortem in
accordance with the guidelines of the ‘‘German Animal Welfare
Act’’ (German: Tierschutzgesetz; 14 Abs. 3). We did not need
formal approval, because the study did not involve any treatments
or harmful procedures. The experiments were notified by animal
welfare office of University Medical Center Go ¨ttingen, Germany.
Tissue preparation and RNA isolation
The kidneys were extracted directly post mortem, washed in
cold PBS and cooled on ice. After removal of the kidneys capsules,
cortical slices were prepared and stored overnight in RNAlaterH
(Applied Biosystems, Germany) at 4uC. Total RNA was isolated
from kidney cortical slices using RNeasyH Mini Kit (Qiagen,
Germany) according to the manufacturer’s recommendations.
Quality and quantity of extracted RNA were determined using
the Agilent 2100 Bioanalyzer (Agilent Technologies, USA) and
NanoDropH ND-1000 Spectrophotometer (Thermo Scientific
NanoDrop Technologies, USA) following the manufacturer’s
protocol. RNAs with a RNA integrity number (RIN) .9 were
used for further experiments.
Microarray procedure and data analyses
For microarray experiments, total RNA from four male and
four female rat cortical kidney slices, each slice as a separate
sample, were analyzed. Microarray preparation was performed as
described previously by Opitz et al. [23] with the following
exceptions: 200 ng of total RNA as starting material, the ‘‘Low
Input Quick Amp Labeling Kit, one-color’’ (Agilent Technologies,
USA), the SurePrint G3 Rat GE 8660K Kit (Agilent Technol-
ogies, USA), and Agilent DNA microarray scanner (G2505C) at
3 micron resolution were used.
Data analyses were also performed as described previously [23]
with the exception that Agilent’s Feature (FE) software version
10.7.3.1 was used. All microarray data were generated conforming
to the Minimum Information About a Microarray Experiment
(MIAME) guidelines and have been submitted to the Gene
Expression Omnibus (GEO) database at http://www.ncbi.nlm.
nih.gov/geo/ (accession number: GSE34565). For evaluation of
sex-different expression profiles four adjustments were made: 1) p-
value,0.05, 2) log2 fold-change (FC)$1 (higher expressed in male
rats) and log2 fold-change (FC)#21 (higher expressed in female
rats), 3) false discovery rate (FDR) ,5%, and 4) duplicated genes
were removed and the ones with the lower log2 fold-change were
kept. To identify genes that are expressed in the rat proximal
tubules candidate genes were aligned with the ‘‘Rat Proximal
Tubule Transcriptome Database’’ (http://dir.nhlbi.nih.gov/
papers/lkem/pttr/). Volcano plot for sex-dependent gene expres-
sion was performed by using plot function in ‘‘R’’ (http://cran.r-
project.org/).
TaqManH real-time polymerase chain reaction
For gene expression analysis, RNA of the four male and four
female rat cortical kidney slices were reverse transcribed using
oligo dT-primer (Eurofins MWG Operon, Germany) and Super-
script
TM II Reverse Transcriptase (Invitrogen, Germany). The
detection of genes of interest was realized by TaqManH Gene
Expression Assays (Applied Biosystems, USA). As endogenous
control, mRNA expression of housekeeping gene beta-actin (b-
actin) or hypoxanthine phosphoribosyltransferase 1 (Hprt1) was
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used: b-actin, Rn00667869_m1; Hprt1, Rn01527840_m1; hepa-
tocyte nuclear factor 1a (Hnf1a), Rn00562020_m1; hepatocyte
nuclear factor 1b (Hnf1b), Rn00447453_m1; hepatocyte nuclear
factor 4a (Hnf4a), Rn00573309_m1; androgen receptor (rAR),
Rn00560747_m1; Oat1, Rn00568143_m1; Oat3,
Rn00580082_m1; polymerase (RNA) III (DNA directed) poly-
peptide G (Polr3g), Rn01494192_m1; hydroxysteroid (17-beta)
dehydrogenase 1 (Hsd17b1), Rn00563388_g1; B-cell CLL/
lymphoma 6 (BCL6), Rn01404339_m1. TaqManH real-time
PCR analysis was performed in a Mx3000P
TM real-time PCR
cycler (Agilent Technologies, USA) with the following parameters:
2 min heating step at 50uC, 10 min hot start at 95uC, followed by
40 cycles of 95uC for 15 s and 60uC for 1 min. The amplification
efficiency of all used TaqManH Gene Expression Assays was 100%
(+/210%), indicating that during PCR amplification the starting
material was amplified by a factor of two during every cycle.
Relative expression levels were analyzed using the 2
2DDCt method
[24], where DDCt is the difference between the selected DCt value
of a sample and the DCt of a control sample. Evaluation of 2
2DDCt
for the samples indicates the fold change in expression relative to
the control.
Data analyses not related to microarray experiments
Data in the figures are presented as mean 6 S.E.M. of either
three or four different experiments. Statistical analysis was
performed using the two-sided unpaired t-test (GraphPad Prism
4, version 4.03). Differences were designated as indicated in the
figures.
Results
Effect of testosterone on Oat1- and Oat3-promoter
constructs in OK cells
In silico analysis of 3 kb upstream of the transcription start site of
Oat1 and Oat3 promoters were investigated using MatInspector.
In both promoters two putative androgen response elements
(AREs) were postulated (Table 2), however none of which showed
a perfectly conserved binding site (consensus sequence: GGTA-
CAnnnTGTTCT) [25,26]. The role of testosterone in the
regulation of Oat1 and Oat3 promoter activity were investigated
using luciferase assays as described in material and methods
(Figure 1). Cellular localization of transfected rAR revealed an
expression with an exclusive nuclear localization (Figure 1A).
Transfection efficiency of rAR was 39.1%. The functional activity
of rAR was confirmed by rat probasin promoter (rPb-Luc), used as
positive control. rPb-Luc was significantly activated by 100 nM
testosterone (Figure 1B). In the absence of rAR, rat probasin
promoter was not enhanced by testosterone, demonstrating that
OK cells do not express endogenous rAR (Figure 1B). The
activation of rPb-Luc is regulated via two functional ARE (Table 2)
[27]. No significant induction by 100 nM testosterone of Oat1-
and as well as Oat3-promoter activities were observed (Figure 1C).
The comparison of Oat1- and Oat3-promoter activity revealed a
stronger basal promoter activity of Oat3 as compared to Oat1
(Figure 1C).
Sex-dependent expression of Oat1 and Oat3 in Han
Wistar rats
Based on TaqManH real-time PCR we investigated the sex-
dependent expression of Oat1 and Oat3 in cortical kidney slices
from four male and four female rats. Since sex differences
were investigated, two reference genes b-actin and Hprt were
used. The mRNA levels of both reference genes were not altered
under the experimental conditions (Figure 2A). TaqManH real-
time PCR revealed sex-dependent expression of Oat1 and Oat3
(Figure 2B). Thereby the sex-dependent difference of Oat1
between male and female was higher as compared to Oat3
(Figure 2B).
Sex-dependent gene expression profiling
The gene expression profiles of cortical kidney slices from the
four male and four female rats used previously, were analyzed
using the SurePrint G3 Rat GE 8660K Microarray Kit from
Agilent Technologies. The volcano plot gives a first overview of
gene expression between males and females (Figure 3). Out of
22,863 investigated probes, 572 exhibit significant [2log10(ad-
justed p-value),0.05] sex-dependent expression (log2 fold-
change#21o r$1) (Figure 3). 293 probes were higher expressed
in females (log2 fold-change#21), and 281 probes were higher
expressed in males (log2 fold-change$1) (Figure 3). After exclusion
of probes with a FDR .5% and probes without Gene ID, 160
genes were higher expressed in females and 175 genes higher in
males (Table S1). The alignment with the ‘‘Rat Proximal Tubule
Transcriptome Database’’ and the removal of duplicated genes
revealed 56 genes with significant sex-dependent expression in
proximal tubule cells (Table 3). Out of these 56 genes, 13 genes
showed a higher expression in females whereas 43 genes showed a
higher expression in males. Genes were classified into different
groups according to their function included: twenty-one enzymes
(186M.F, 36F.M), nine membrane proteins and receptors
(76M.F, 26F.M), two transcription factors (16M.F,
16F.M), six transport proteins (46M.F, 26F.M), six signal
transduction (46M.F, 26F.M) and twelve other genes
(96M.F, 36F.M) (Table 3). TaqManH real-time PCR was
used to verify selected microarray results. Seven genes were
chosen as a result of their possible involvement in the
transcriptional regulation of the sex-dependently expressed
Oat1 and Oat3: Hnf1a, Hnf1b, Hnf4a, rAR (GSE34565),
Hsd17b1, BCL6, and Polr3g (bold letters in Table 3). All
three validated hepatocyte nuclear factors (Hnf1a, Hnf1b,
and Hnf4a) showed no sex-dependent expression (Figure 4),
confirming the microarray results (GSE34565). Validation of rAR
showed a significant male-dominant expression (Figure 4). This
result did not coincide with that indicated by microarray where
rAR showed no sex-dependent expression (GSE34565). The
levels of Polr3g, Hsd17b1, and BCL6 were clearly higher in
males as compared to females (Figure 4), confirming the
microarray results (Table 3).
In silico analyses of potential BCL6 binding sites in the
Oat1- and Oat3-promoter region
In the analyzed Oat1-promoter there are five potential BCL6
binding sites postulated none of which was a perfectly conserved
binding site (consensus sequence: TTCCT(A/C)GAA) [28]
(Table 2). In silico analysis of the Oat3-promoter revealed six
potential BCL6 binding sites, of which none did correlate
completely with the consensus sequence (Table 2). The promoter
construct Oat1 (21266/+113) included two predicted BCL6
binding sites, the Oat1 (21666/+113) construct included four
predicted BCL6 binding sites and the Oat1 (22252/+113)
included four predicted BCL6 binding sites (Table 2).
The shortest promoter construct Oat3 (2444/+12) has two
predicted BCL6 binding sites (Table 2). In the Oat3 promoter
construct (2752/+12), three BCL6 responsive elements are
located. The longest Oat3 promoter construct (22567/+12)
included six BCL6 binding sites (Table 2).
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As a positive control for transfection and expression in OK cells,
BCL6 expression was investigated using immunofluorescence
(Figure 5A). Characterization of BCL6 cellular localization
revealed an exclusive nuclear localization (Figure 5A). Transfec-
tion efficiency of BCL6 was 23,3%. To test for a possible influence
of BCL6 on the promoters of Oat1 and Oat3, OK cells were
transfected with different promoter constructs, pcDNA3-BCL6 or
empty pcDNA3 vector, and their luciferase activity were measured
(Figure 5B and 5C). All three Oat1-promoter constructs showed a
significant activation by BCL6 compared to the control
(Figure 5B). The promoter constructs Oat3 (2444/+12) and
(2752/+12) were activated by BCL6 (Figure 5C). The promoter
activity of the longest Oat3 construct (22567/+12) was not
significantly altered but showed a positive trend for an activation
by BCL6 (Figure 5C).
Discussion
The aim of this study was to identify sex-dependently expressed
genes in the rat proximal tubule cells that may be involved in the
transcriptional regulation of Oat1 and Oat3. Since 1955 it is
known that the uptake of the typical Oat1 substrate, p-
aminohippurate (PAH), by rat renal cortical slices is higher in
Figure 1. Effect of testosterone on probasin, Oat1- and Oat3-promoter activity. OK cells were either transfected with pSG5 or pSG5-rAR,
and rAR expression and cellular localization were analyzed using immunofluorescence staining (green color rAR, blue color DAPI staining; excitation
wavelength 488 nm and 365 nm) (1A). Promoter constructs of rat probasin, Oat1 and Oat3, and the expression vector for rAR were transiently
transfected into OK cells (1B and 1C). Cells were cultured 43 h with either 100 nM testosterone (black bars) or with 0.0003% DMSO as control (white
bars) (1B and 1C). Luciferase activity was measured and firefly luciferase was normalized to Renilla luciferase. Data are reported as the fold increase
presented as mean 6 S.E.M.; n=4; n.s.: not significant; ***: p,0.001, significantly different from control (0.0003% DMSO).
doi:10.1371/journal.pone.0035556.g001
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uptake [30] possibly by having a positive influence on the
expression of functional transporting proteins [31]. PAH is
absorbed from the blood into proximal tubule cells by Oat1 and
Oat3 in rat kidneys [32–36] and, in rat renal proximal tubule cells,
a higher expression of Oat1 and Oat3 in males compared to
females has been reported [19,37]. Moreover, it has been shown
that Oat1 and Oat3 expression is increased by testosterone [19].
Two different AREs were predicted in the promoter of Oat1 and
Oat3 in our in silico analysis. Surprisingly, testosterone showed no
stimulating effect on the promoter activity of Oat1 and Oat3,
although the minimal promoter of rat probasin (rPb-Luc) was
activated under the same conditions. These results suggest that the
predicted AREs in the promoter of Oat1 and Oat3 are not
functional, and that these transport proteins are not directly
activated by the classical androgen receptor mediated transcrip-
tional pathway. Given the known sex-dependent expression of
Oat1 and Oat3 in rat proximal tubule cells [19,37], we concluded
that hitherto unknown factors are involved in the transcriptional
male-dominant expression of Oat1 and Oat3.
Table 2. In silico analyses of Oat1 and Oat3 promoter.
Promoter (3 kb) Binding site Sequence Position
Oat1 ARE 59-gcaggactcagtgttttgt-392 2006 to 21988
ARE 39-gtagccctggctgtcctgg-592 1655 to 21637
BCL6 59-tctttcctggtaagaga-392 2352 to 22336
BCL6 59-gagttccaggacagcca-392 1660 to 21644
BCL6 59-taatttttagaaataaa-392 1295 to 21279
BCL6 59-ctgttcctacaagttat-392 1143 to 21127
BCL6 59-tatttcccagagcccag-3 2492 to 2476
Oat3 ARE 59-ggctgcctacctgttctgt-392 2863 to 22845
ARE 59-gttgggctctgtgtactct-392 1923 to 21905
BCL6 39-accttccgtgaaaaaca-592 2055 to 22039
BCL6 59-gggtccctggaaatagt-392 1366 to 21350
BCL6 59-gacttcatagaaaactc-392 1174 to 21158
BCL6 59-atactcatagaaataaa-392 614 to 2598
BCL6 39-aggttcgtggagaatgt-592 439 to 2423
BCL6 59-cccttcccagattctct-392 279 to 2263
Probasin minimal promoter (2426 to +28 bp) ARE a) 59-tgatagcatcttgttctta-3 2243 to 2225
ARE a) 59-taggttcttggagtacttt-392 138 to 2120
consensus sequence: ARE ggtacannntgttct [25,26]
consensus sequence: BCL6 ttcct(a/c)gaa [28]
Oat: organic anion transporter; ARE: androgen response element; BCL6: B-cell CLL/lymphoma 6;
n: any nucleotide, a) functional ARE published in [27].
doi:10.1371/journal.pone.0035556.t002
Figure 2. Sex-dependent expression of Oat1 and Oat3 in rat cortical kidney slices. Levels of b-actin, Hprt1, Oat1 and Oat3 were analyzed
by TaqManH real-time PCR in total RNA isolated from four male and four female cortical kidney slices. The mRNA expression of reference genes b-
actin and Hprt1 were investigated by comparing their Ct values between male and female (2A). Levels of Oat1 and Oat3 were determined using
2
2DDCt method, at which b-actin was the reference gene (2B). DDCt values were calculated as DCt male - DCt female. nmale=4;n female=4.
doi:10.1371/journal.pone.0035556.g002
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17,406 different genes and found that only 56 genes were
significantly sex-dependently expressed. This relatively small
number of sex-dependently expressed genes is due to the fact that
we only analyzed genes that are localized within the proximal
tubule cells. The promising Oat1 and Oat3 regulators, Hnf1a,
Hnf1b, and Hnf4a are expressed in the proximal tubule cells
(http://dir.nhlbi.nih.gov/papers/lkem/pttr/), but revealed no
sex-dependent expression in our microarray analysis and real-
time PCR. For human OAT1-promoter the activation by HNF4a
was demonstrated [38]. The promoters of mouse Oat1, human
OAT1 and OAT3 are activated by HNF1a and HNF1b [39,40].
The possible Oat1 and Oat3 regulator, rat androgen receptor
(rAR) that is expressed in the proximal tubule cells (http://dir.
nhlbi.nih.gov/papers/lkem/pttr/) showed no sex-dependent ex-
pression in the microarray, but demonstrated a significant male-
dominant expression by real-time PCR. The decreased sensitivity
of microarrays in comparison to real-time PCR may explain the
different results. It is known that both real-time PCR and
microarray analysis have inherent pitfalls that could influence
the data obtained from each method, resulting in disagreement
[41]. The false discovery rate (FDR) of rAR was about 24%,
indicating a false positive microarray result that was verified by
real-time PCR revealing a significant male-dominant expression.
Despite the higher expression of rAR in the male kidneys, rAR is
probably not a direct regulator of Oat1 and Oat3 promoters, as we
could demonstrate in our study.
Out of the 56 sex-dependently expressed genes three genes that
showed a male-dominant sex-dependent expression in the
microarray, Polr3g, Hsd17b1, and BCL6 were selected for
verification. The real-time PCR analysis clearly confirmed the
microarray results for these three genes.
The first validated gene was Polr3g that is a subunit of the
dissociable RNA polymerase (pol) III subcomplex [42]. Pol III
transcribes especially short non-coding RNAs, for example tRNA,
5S RNA, 7SK RNA, U6 small nuclear RNA and H1 RNA that
are involved in processing of pre-rRNA, mRNA and tRNA
[42,43]. This subcomplex is responsible for the initiation of Pol III
transcription [42]. This so far unknown male-dominant Polr3g
expression could enhance the initiation of pol III transcription,
leading possibly to a rather indirect effect on the expression of
Oat1 and Oat3.
Hsd17b1 was the second validated gene and represents a
promising candidate gene for sex-dependent Oat1 and Oat3
regulation. Members of the 17b-hydroxysteroid dehydrogenase
(HSDs) family play an important role in the estrogen and
androgen steroid biosynthesis [44–46]. Human HSD17b1 selec-
tively converts estrone to estradiol [44]. The rat Hsd17b1 mediates
the reduction of androstenedione to testosterone as efficiently as
the analogous reduction from estrone to estradiol [47]. The male-
dominant renal Hsd17b1 expression could be responsible for an
increased testosterone concentration in proximal tubule cells. The
increase of Oat1 and Oat3 protein expression by testosterone was
published [19], but this increase is potentially not mediated by the
classical androgen receptor mediated transcriptional pathway as
demonstrated in our contribution. Possibly, the elevated testoster-
one concentration could activate a, till now unknown, transcrip-
tion factor, which then activates Oat1 and Oat3 expression.
The third real-time PCR validated gene was the transcription
factor BCL6, that was identified and characterized in B-cells [48].
BCL6 is necessary during embryonic development, plays a role in
germinal center formation, and is essential in the immune response
[28,48]. BCL6 has also been reported to be a proto-oncogen,
whereby the intact coding sequence of BCL6 is often translocated,
obtaining a new changed 59 non-coding promoter region [28]. In
many cases BCL6 acts as a transcriptional repressor due to its
ability to recruit the known transcriptional repressors nuclear
receptor corepressor (N-CoR), silencing mediator of retinoid and
thyroid receptor (SMRT), and BCL6 interacting corepressor
Figure 3. Volcano plot of microarray analysis. In this microarray a
total of 22,863 probes were analyzed. On the y-axis the negative log10
of the adjusted p-value and on the x-axis the log2 of the fold-change is
plotted. Each probe is represented as a dot. Low p-values (highly
significant) are localized at the top of the plot. Probes that are
expressed higher in females have a negative log2 fold-change
appearing at the left side and probes that are expressed higher in
males have a positive log2 fold-change appearing at the right side. The
horizontal red line denotes the threshold for p=0.05. The vertical red
lines denote the two-fold thresholds.
doi:10.1371/journal.pone.0035556.g003
Figure 4. Verification of microarray results using TaqManH
real-time PCR. Gene expressions were verified by TaqManH real-time
PCR in total RNA isolated from four male and four female cortical kidney
slices. Levels of all genes were determined using 2
2DDCt method, at
which b-actin was the reference gene. DDCt values were calculated as
DCt male - DCt female. nmale=4;n female=4.
doi:10.1371/journal.pone.0035556.g004
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Symbol Description log2 FC (m- f) P. Value (m-f) FDR (m-f)
ENZYMES
Aldh1a1 aldehyde dehydrogenase 1 family, member A1 1,01 3,85E-06 0,09%
Baat bile acid Coenzyme A: amino acid N-acyltransferase (glycine N-choloyltransferase)
choloyltransferase)chcchcholoyltransferasecholoyltransferasecholoyltransferase)
21,24 1,22E-03 2,40%
Cth cystathionase (cystathionine gamma-lyase) 21,01 1,24E-04 0,61%
Cyp2d4v1 cytochrome P450, family 2, subfamily d, polypeptide 4 1,11 4,39E-06 0,10%
Cyp4a2 cytochrome P450, family 4, subfamily a, polypeptide 2 3,03 9,25E-04 2,04%
Ddx19a DEAD (Asp-Glu-Ala-Asp) box polypeptide 19a 1,05 6,57E-05 0,43%
Dnm3 dynamin 3 2,64 2,16E-07 0,03%
Eepd1 endonuclease/exonuclease/phosphatase family domain containing 1 1,02 2,67E-04 0,98%
Es22 esterase 22 2,02 3,16E-07 0,03%
F3 coagulation factor III (thromboplastin, tissue factor) 1,10 2,80E-05 0,27%
Hao1 hydroxyacid oxidase (glycolate oxidase) 1 1,88 1,24E-04 0,61%
Hmgcs2 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 (mitochondrial) 3,30 9,19E-06 0,16%
Hsd17b1 hydroxysteroid (17-beta) dehydrogenase 1 1,52 1,93E-05 0,23%
Oat ornithine aminotransferase (gyrate atrophy) 21,36 3,03E-05 0,28%
Pecr peroxisomal trans-2-enoyl-CoA reductase 1,15 9,75E-05 0,53%
Proc protein C 1,01 2,22E-07 0,03%
Ptgds prostaglandin D2 synthase (brain) 2,19 2,46E-06 0,08%
Rasa2 RAS p21 protein activator 2 1,04 5,92E-05 0,41%
Rasl12 RAS-like, family 12 2,18 2,12E-05 0,24%
Rdh2 retinol dehydrogenase 2 1,56 4,49E-04 1,31%
Usp9x ubiquitin specific peptidase 9, X-linked 2,35 2,53E-03 3,60%
MEMBRANE PROTEINS/RECEPTORS
Asgr1 asialoglycoprotein receptor 1 1,49 3,35E-05 0,29%
B4galt5 UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 5 1,00 1,23E-05 0,18%
Cd1d1 CD1d1 molecule 21,14 7,03E-04 1,74%
Kifc1 kinesin family member C1 1,37 3,41E-05 0,29%
Prlr prolactin receptor 1,14 1,82E-04 0,78%
Sectm1b secreted and transmembrane 1B 1,21 5,43E-05 0,40%
Stra6 stimulated by retinoic acid gene 6 21,16 9,07E-06 0,16%
Tmem144 transmembrane protein 144 1,02 3,89E-05 0,32%
Trim59 tripartite motif-containing 59 1,02 5,78E-06 0,12%
TRANSCRIPTION FACTORS
Arid3b AT rich interactive domain 3B (Bright like) 21,48 1,65E-04 0,73%
Bcl6 B-cell CLL/lymphoma 6 2,18 1,61E-05 0,21%
TRANSPORT PROTEINS
Abca7 ATP-binding cassette, sub-family A (ABC1), member 7 21,35 1,40E-05 0,19%
Abcb1b ATP-binding cassette, sub-family B (MDR/TAP), member 1B 22,66 3,96E-03 4,65%
Ostalpha organic solute transporter alpha 1,13 3,06E-05 0,28%
Slc10a1 solute carrier family 10 (sodium/bile acid cotransporter family), member 1 1,12 3,98E-04 1,21%
Slc30a2 solute carrier family 30 (zinc transporter), member 2 1,26 7,12E-06 0,13%
Ust5r integral membrane transport protein UST5r 1,07 1,85E-04 0,79%
SIGNAL TRANSDUCTION
Cklf chemokine-like factor 21,03 6,79E-05 0,44%
Cks2 CDC28 protein kinase regulatory subunit 2 1,06 3,81E-03 4,55%
Dock5 dedicator of cytokinesis 5 21,58 1,75E-03 2,93%
Fgf13 fibroblast growth factor 13 1,12 3,32E-06 0,09%
Gas2 growth arrest-specific 2 1,40 5,73E-07 0,04%
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histone deacetylases 1 and 2 [48]. BCL6 inhibits the expression of
different genes like p21 and cyclin D2 [28,48]. Moreover it could
repress the activity of NFkB by a direct protein-protein interaction
between BCL6 and the subunits of NFkB [49]. BCL6 could also
act as an activator leading to alteration in the growth cycle of the
cell [50]. In our study, a considerably higher BCL6 expression in
males compared to females was found. A comparable male-
dominant expression of BCL6 has been demonstrated in the rat
liver, whereas a possible role of BCL6 in the regulation of Oats has
not been investigated [51]. Although all three validated genes are
promising candidate genes for sex-dependent regulation of Oat1
and Oat3, we decided to focus on the possible involvement of
BCL6 as a result of predicted BCL6 binding sites in the Oat1 and
Oat3 promoter region.
BCL6 is known to bind to a specific DNA sequence with a core
sequence of TTCCT(A/C)GAA [28]. Luciferase activity assays
revealed a significant activation of Oat1 as well as Oat3 promoter
by BCL6. All three Oat1 as well as Oat3 promoter constructs
contain predicted BCL6 binding sites. Regarding the amplitude of
fold induction, all Oat1 constructs were activated to a comparable
amount, indicating that the first and/or second BCL6 binding site
is may be the critical site for activation of Oat1 promoter
constructs by BCL6. Oat3 promoter constructs were also activated
to a comparable extent by BCL6 and possibly directly regulated
via first and/or second BCL6 binding site. Our results implicate
that male-dominant BCL6 is a promising transcription factor in
the promoter activation of sex-dependently expressed Oat1 and
Oat3. Interestingly, BCL6 is able to repress the activity of NFkBa t
the post-transcriptional level due to protein-protein interaction
[49]. In renal ischemia the expression of rat renal Oat1 and Oat3
was decreased [52], and that of NFkB was increased [53].
Therefore it is possible that male-dominant BCL6 expression
suppresses the activity of NFkB, leading indirectly to the higher
expression of Oat1 and Oat3 in males. NFkB itself is expressed in
the proximal tubule cells (http://dir.nhlbi.nih.gov/papers/lkem/
pttr/) but exhibited no sex-dependent expression in our micro-
array analysis (GSE34565).
This study presents a first description of sex-dependent gene
expression in the kidneys and especially in the proximal tubule
cells (GSE34565). The sex differences were identified in several
gene groups, e.g. enzymes, membrane proteins and receptors,
transcription factors, transport proteins, genes involved in the
signal transduction pathways, and others. Some candidate genes
like Polr3g, Hsd17b1 and BCL6 might be directly or indirectly
involved in sex-dependent expression of Oat1 and Oat3. Our
results showed that BCL6 activated the promoters of Oat1 and
Oat3 and constituted a promising candidate gene for their sex-
dependent regulation. To further elucidate the involvement of
BCL6 in the sex-dependent expression of Oat1 and Oat3,
additional experiments are required.
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cal kidney slices. FC: log2 fold-change (FC)#21o r$1, FDR:
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positive log2 FC representing higher expression in males. Probes
with a FDR .5% and probes with no Gene ID are excluded in
this list.
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Table 3. Cont.
Symbol Description log2 FC (m- f) P. Value (m-f) FDR (m-f)
Nrep neuronal regeneration related protein 1,16 2,97E-04 1,02%
OTHERS
Cldn1 claudin 1 21,54 5,66E-07 0,04%
Ddit4l DNA-damage-inducible transcript 4-like 21,76 3,62E-03 4,40%
Espn espin 1,21 1,31E-03 2,51%
Klhl14 kelch-like 14 (Drosophila) 21,31 2,68E-05 0,27%
Mlph melanophilin 1,91 1,53E-06 0,06%
Obfc2a oligonucleotide/oligosaccharide-binding fold containing 2A 1,17 2,45E-05 0,26%
Picalm phosphatidylinositol binding clathrin assembly protein 1,14 2,96E-06 0,08%
Polr3g polymerase (RNA) III (DNA directed) polypeptide G (32 kD) 1,34 3,14E-05 0,28%
Rpp25 ribonuclease P 25 subunit (human) 1,77 4,64E-05 0,35%
Rufy3 RUN and FYVE domain containing 3 1,06 2,06E-03 3,20%
Spc25 SPC25, NDC80 kinetochore complex component, homolog (S. cerevisiae) 1,02 1,73E-03 2,92%
Tox thymocyte selection-associated high mobility group box 1,07 1,81E-05 0,22%
FC: log2 fold-change (FC)#21o r$1; FDR: false discovery rate ,5%; P. value: p,0.05; (m-f): male-female. Genes are grouped, and displayed within these groups in an
alphabetical order. Genes shown with a negative log2 FC are higher expressed in females while genes with a positive log2 FC are higher expressed in males. The
expression of all genes was aligned with (http://dir.nhlbi.nih.gov/papers/lkem/pttr/). Bold marked genes were selected for verification by TaqManH real-time PCR.
doi:10.1371/journal.pone.0035556.t003
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